Detect
Destroy
Attack
In an age where pandemics, bioterrorism, and synthetic biology have turned biology into a new battlefield, humanity needs a new kind of soldier—one that doesn’t wear armor, but senses, neutralizes, and defends from the inside out.
bioDrone™ is that soldier.
The bioDrone™ Mechanism: Smart Biology Meets Quantum Defense
At its core, bioDrone:tm: uses a quantum biosensor enhanced by AI-driven protein domain modeling. This allows it to mimic the exact human cell receptor sites that viruses or bacteria use to bind and invade the body.
• Using computational AI, we map the binding domains—the specific proteins on human cells that pathogens exploit.
• We then engineer synthetic molecular traps that mimic these domains and invite the pathogen to attack—a biochemical honeypot.
• When the virus or bacteria binds to the synthetic molecule, it triggers a quantum energy transfer—a burst of quantum-level charge transfer that destroys the pathogen and the synthetic molecule, mimicking the function of a suicide bio-drone.
This detection-attack-destroy mechanism is not passive testing. It’s active countermeasure technology, built on precision biophysics and intelligent design. Every interaction is logged and learned, strengthening the system’s ability to predict, trap, and kill ever-evolving threats.
How bioDrone™ Works: Quantum Biosensing Meets AI-Driven Immunity
At the core of bioDrone:tm: is a proprietary quantum biosensor platform, enhanced by AI-modeled receptor mimicry. Here’s how it operates:
1. Molecular Trap Construction:
Using computational AI, bioDrone models the precise binding domains that pathogens (viruses, bacteria, toxins) use to latch onto human cells.
2. Synthetic Lure Deployment:
We engineer synthetic molecular traps that perfectly mimic those human cell receptors. This invites the pathogen to bind—thinking it has found a human host.
3. Quantum Counterattack:
The moment the pathogen binds, a quantum energy transfer is triggered, resulting in the destruction of both the pathogen and the synthetic cell—functioning like a biological suicide drone.
4. Distributed Early Warning System:
Every engagement is logged. Every attack strengthens our defense network. The system learns, adapts, and evolves in real-time.
Why bioDrone™ is Mission Critical
• Bioweapon Readiness: Next-gen synthetic pathogens can target populations. bioDrone neutralizes them before clinical signs even emerge.
• Zoonotic Spillovers: Climate change is accelerating animal-human transmission. bioDrone meets it at the interface.
• Border & Critical Infrastructure Defense: Detecting pathogens in airports, embassies, military bases, labs, and supply chains becomes possible at a quantum level.
• Healthcare System Relief: Hospitals can shift from reactive treatment to proactive biological containment.
bioDrone™ is not passive detection—it is proactive defense.
An intelligent, quantum-powered immune system—decentralized, adaptive, and self-sacrificing.
It detects. It attacks. It destroys.
And most importantly, it defends humanity’s future.
The
Technology
Rapid development of new bioDrones that specifically targets the new biothreat is criticial along with portable detection equipment. Whether a country is securing its boarders or securing your home, our device technololgy can detect the pathogen in many settings, including in the human body.
Virus Detection in the BioDefense Zone
Before Symptoms, Before Contagious
Ease of Sample Collection in Saliva
Saliva Activator (patent pending) a single step process to filter, mix and read the virus binding
Computational AI for Synthetic bioDrone creation
Rapid analysis and synthsis to mass produce bioDrone for deployment across the world
Portable Devices for Boarders and Homes
Real time detection of viruses and bacteria at the point on entry is critical for biodefense
SFS Portable Lab - "Lab on the Go" for detection of Viruses and Bacteria, Spores and Toxins
Advanced portable detection system can be quickly configured by changing the sensor gun to detect on sufaces for bacteria, in water, in air, and for virusues. For viruses surface detection and human saliva detection is done simple by changing the hand help sensor.
This is an advanced resaerch device used by biodefense teams to collect forensic information on contaminated sites.
Handheld BioDefense for rapid detection of Bacteria, Spores and Toxins
Rapid detction of clusteres of pathogens for use in hospitals, or in the field for biowarfare elaryl warning. This handheld deteciton system is in use by military operations for early detection of bacteria.
Use can be for quick assessment in hospitals, assited living homes, clinics, kitchens, bathroom or any location that harmful bacterai may occur.
Will detect the cluster but will not identify the specific bacteria type. Lab on th Go is used for specific bacteria indentification.
Point of Care or Entry for Virus Detection
Low cost detction device for suface bacterai detection or throat swab testing of himans. Can detect within 1 minute the presence of a virus on the swab, the viral load and the virur varaint of any class of virus the a bioDrone has been targeted.
The mini_lab for the Home
For at Home testing for various viruses can be detected by taking a throat swab and applying it to the target bio-chips on the catridge. The individual virion will bind with the receptor fized to a multi-layer biochip and upon binding will be detected by the photon detector in the device.
This cartridge is also designed for taking a blood sample to detect bacteria and viruses in the blood.
The
Roadmap
The original discovery of synthsizing human cells that biomimic the receptors that pathogens bind too in order to effect a quantum energy trasnsfer from the pathogen to the drone receptor was discoverd in 2015. We alos discoverd that when a pathgen binds to our biodrone, the energy transfers kills the pathogen. We can sense this energy trasnfer, detecting the pathogen type and presense. The following timeline and road map provides the history and future for the technology. The timeline below detail the history of the technology development by multiple international comoanies leading up to the commercial license with CNER.
Management
Team
Gary Bartholomew - CEO and Director
Gary Bartholomew, a graduate of the University of Waterloo, brings extensive experience in innovation-driven leadership to his role as Executive Director of Thrive Precision Health Research. With a strong background in technology development and commercialization, Gary leads the nonprofit’s mission to advance groundbreaking solutions for managing and slowing the progression of metabolic disorders, including type 2 diabetes. Under his guidance, Thrive conducts clinical studies and validations to bridge the gap between cutting-edge research and real-world application, empowering global healthcare systems with effective, evidence-based tools to combat chronic diseases. Gary’s passion for driving impactful change inspires the organization’s collaborative efforts to transform lives through science and innovation.